PubMed HealthSearch

Biomedical subjects

C M Newton

Publications and source records attributed to C M Newton.

10 recordsLinked to original sources

An interactive graphics information system for familial data.

GRIFFIN, an interactive graphics system for studying familial information, facilitates viewing of complex databases and introduces graphical representations of multivariate scalar data into a conventional pedigree display format.

Computer Graphics

Campylobacter infection in a closed dog breeding colony.

Most dogs in a closed breeding unit were shown to be asymptomatic excretors of campylobacter organisms by eight weeks old. Increasing serum antibody levels, which were correlated with the excretion of organisms, were demonstrated in the puppies and serum antibodies were also demonstrated in adult dogs. The significance of these findings with respect to the pathogenicity of campylobacter in dogs and their zoonotic implications are discussed.

Animals

Technique for guiding catheter exchange during coronary angioplasty while maintaining guidewire access across a coronary stenosis.

This case report describes a technique for guiding catheter exchange while angioplasty extended guidewire access is maintained across a coronary artery stenosis with a 245-cm-0.035-in.-long wire in the aorta to exchange for a more favorable guiding catheter. The indications, technique, and outcome of a case are described; it illustrates the usefulness of maintaining angioplasty guidewire access in a difficult-to-cross coronary stenosis.

Aged

Mebendazole for worming mice: effectiveness and side effects.

The use of mebendazole-treated diet (60 ppm) effectively controlled Hymenolepis nana and Aspiculuris tetraptera in a large mouse breeding colony. In a 3 generation pilot study using a medicated diet, there was some reduction in litter size and in female growth rate and an overall 2.07% incidence of kinky tails in the offspring. When the whole mouse colony was fed mebendazole-treated diet, a high incidence of kinky tails (maximum 46% of weaned offspring) occurred.

Abnormalities, Drug-Induced

Applications of percutaneous transluminal coronary angioplasty in cardiac transplantation. Preliminary results in five patients.

Atherosclerotic coronary artery disease is the major cause of late cardiac transplant failure secondary to silent ischemia and infarction. To increase the longevity of cardiac homografts, we performed percutaneous transluminal coronary angioplasty (PTCA) in five male patients (aged 45 +/- 7 years, mean +/- SEM); 17 lesions were dilated during eight procedures 83 +/- 11 months after cardiac transplant. PTCA was successful (greater than or equal to 20% change in vessel diameter) in 13 of 17 (76%) lesions (the degree of prePTCA stenosis was 84% +/- 3% vs. 40% +/- 4% postPTCA; p less than or equal to 0.01). Multiple PTCA procedures were performed for progressive coronary artery disease in two patients; in one patient, two procedures were 13 months apart, and, in the second patient, another three procedures were 2 and 6 months apart. Indications for PTCA included reversible thallium perfusion defects, segmental left ventricular wall-motion abnormalities, or both in the distribution of proximal coronary artery stenoses. No deterioration occurred in the four unsuccessful PTCA attempts (two patients with initial total occlusion, and two patients in whom the lesion could not be crossed with a guidewire). Noninvasive evidence of ischemia was improved immediately after PTCA in all cases. Three patients remain alive 5, 7, and 11 months, respectively, after PTCA without evidence of new ischemia. One patient died 39 months after his first PTCA, while another patient was retransplanted 8 months after the first PTCA. Thus, PTCA can be performed in cardiac transplant patients with proximal major vessel coronary artery disease and may prolong cardiac homograft function.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult